R. Swamy Venuturupalli, MD, FACR
Dr. Venuturupalli, founder of Attune Health, is a preeminent authority in the field of rheumatology. After graduating from the National Medical College in Mumbai, India, he completed his residency as Chief Resident at the State University of New York Upstate Medical University in Syracuse, New York.
He received advanced training in health services research at UCLA where he conducted pioneering research on complementary and alternative medicine, publishing studies on Ayurvedic medicine, dietary supplements and mind-body medicine. Dr. Venuturupalli also completed a rheumatology fellowship at the UCLA-Olive View medical program.
One of the nation’s most renowned and innovative rheumatology researchers, Dr. Venuturupalli is involved in over 100 clinical trials for illnesses such as lupus, rheumatoid arthritis, myositis, psoriatic arthritis and other autoimmune diseases at the Cedars-Sinai Medical Center’s Division of Rheumatology.
He has published several peer-reviewed articles and textbook chapters, and has served as the Editor-in-Chief of Current Rheumatology Reviews. Dr. Venuturupalli is often sought out as a teacher in his field of expertise and is an Associate Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA. His current research efforts are focused on how technology can be used to solve healthcare problems, and he serves as the American College of Rheumatology Chair of the Subcommittee for Technology in Medicine.
Dr. Venuturupalli is highly regarded by his colleagues and patients for his outstanding level of service, dedication to patients and advanced treatment options that result from his medical research and efforts to increase awareness of illnesses related to inflammation and autoimmune disorders and diseases. He has served as the past secretary, treasurer and president of the Southern California Rheumatology Society, and as Clinical Chief of the Division of Rheumatology at Cedars-Sinai Medical Center. He is the founder of the Attune Health Foundation and is actively engaged with the Arthritis Foundation and Lupus LA in their efforts to find a cure for rheumatologic diseases.